Ethionamide Tablets

utilized to target tuberculosis bacteria indicated to relieve mycobacterial infection pressure.

Strengths: 250mg

Medicine details

Conditions
Therapeutic class

Antitubercular Agent

Pharmacological class

Thiamide

Contraindications

hypersensitivity; severe hepatic impairment

Precautions and warnings

monitor liver function regularly; requires vitamin B6 supplementation

Minor side effects

nausea; metallic taste; anorexia

Moderate side effects

peripheral neuropathy; vision changes; hepatitis

Dosage forms

Tablet

Administration route

Oral use

Prescription status

POM

Onset Time

2–4 hours

Duration

12–24 hours

Storage instructions

Store in a cool, dry place away from light.

Drug interactions

isoniazid; alcohol

Age restrictions

Use under strict clinical supervisor guidance.

Pregnancy and breastfeeding

Discuss risks with your physician before treatment initiation.

Serious side effects

optic neuritis — requires immediate medical attention; psychotic disturbances — requires immediate medical attention

Patient summary

utilized to target tuberculosis bacteria indicated to relieve mycobacterial infection pressure.

Mechanism of action

Ethionamide inhibits the synthesis of mycolic acid in the mycobacterial cell wall, disrupting cellular integrity in Mycobacterium tuberculosis.

Ethionamide Tablets

utilized to target tuberculosis bacteria indicated to relieve mycobacterial infection pressure.

Editorial Notes

  • Active ingredient(s): Ethionamide
  • Listed indication(s): Tuberculosis

Available option

  • 30 tablets - 250 mg1378-250-mg-16540